Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Solving the Unsolvable Redefining drug discovery at the molecular level By combining the technology and data engine of Harvard’s Weitz Lab and the University of Cambridge’s Knowles Lab, we created the only end-to-end condensate drug discovery platform built on molecular insights.More About Us ⟶.

News

News pharmabiz.com 10 months ago
Transition Bio & Voyager collaborate to advance small molecules targeting TDP-43 in ALS and frontotemporal dementia
Transition Bio & Voyager collaborate to advance small molecules targeting TDP-43 in ALS and frontotemporal dementia
Read more
Report
News YahooFinance 10 months ago
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally
Read more
Report
News YahooFinance 10 months ago
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking traditionally
Read more
Report
Pro access
Upgrade to see all 13 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

George Martin
Executive Officer, Director
Stephanie Torruella
Executive Officer
Tuomas Knowles
Director
Gregory Miller
Executive Officer, Director
Martin Kulander
Executive Officer
Preet Makkar
Executive Officer
Shaan Gandhi
Director
Samuel Cohen
Director
Al Sandrock
Director
Kathy Yi
Director
Connor McDermott
Director
Robert Weeks
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge United States
HQ
50-200 est. staff

Financials

Total raised
$58.4M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $13.3M Details
Debt Financing 2023 $6M Details
Venture - Series Unknown 2022 $39.1M Details